Machavert Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Machavert Pharmaceuticals LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11139
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Machavert Pharmaceuticals LLC (Machavert Pharmaceuticals) is a bio-pharmaceutical company which develops novel non-toxic medicines for the treatment of cancer and autoimmune diseases. Its lead drug candidate MP1000, a nanoparticulate liposomal phospholipid immune-modulating agent exhibits anti-cancer efficacy and harness the power of human immune system to treat pancreatic cancer and glioblastoma. Machavert Pharmaceuticals focuses on preclinical research and development of new drug candidates such as MP2000, MP3000, and MP4000 that utilize phospholipid platform in tumor specific drug delivery and immuno-oncology. The company works in partnership with other biotechnology companies which provide research and development expertise as well as manufacturing of its drug candidates. Machavert Pharmaceuticals is headquartered in Aurora, Colorado, the US.

Machavert Pharmaceuticals LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Machavert Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Machavert Pharmaceuticals LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Machavert Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Machavert Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Machavert Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Machavert Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Machavert Pharma to Raise USD2 Million in Second Tranche of Series A Financing 10
Machavert Pharma Raises USD2.2 Million in First Tranche of Series A Financing 11
Machavert Pharma Raises USD1 Million in Seed Financing 12
Machavert Pharmaceuticals LLC – Key Competitors 13
Machavert Pharmaceuticals LLC – Key Employees 14
Machavert Pharmaceuticals LLC – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Strategy And Business Planning 16
Mar 24, 2017: Machavert: Bio-lab Up and Running 16
Corporate Communications 17
Feb 01, 2018: Dr. Neal Goodwin Joins Machavert as Chief Science Officer 17
Jan 17, 2018: Machavert Welcomes Dennis R. Voelker as a Member of Science Advisory Board 18
Oct 24, 2017: Machavert Establishes Science Advisory Board 19
Jan 05, 2017: Machavert Hires Jason and Mani 20
Product News 21
03/06/2018: Machavert Welcomed Prof. David Brautigan to His First Meeting at Our Science Advisory Board 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Machavert Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Key Facts 2
Machavert Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Machavert Pharmaceuticals LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Machavert Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Machavert Pharmaceuticals LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Machavert Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Machavert Pharma to Raise USD2 Million in Second Tranche of Series A Financing 10
Machavert Pharma Raises USD2.2 Million in First Tranche of Series A Financing 11
Machavert Pharma Raises USD1 Million in Seed Financing 12
Machavert Pharmaceuticals LLC, Key Competitors 13
Machavert Pharmaceuticals LLC, Key Employees 14

List of Figures
Machavert Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Machavert Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Machavert Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Machavert Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Machavert Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Machavert Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Machavert Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Machavert Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Machavert Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ardelyx Inc (ARDX):企業の財務・戦略的SWOT分析
    Summary Ardelyx Inc (Ardelyx) is a developer of small molecule therapeutics for treatment of cardio-renal, gastrointestinal and metabolic disorders. The company provides product portfolio such as tenapanor, RDX227675, RDX98940 and RDX013, among others. Its products are used for hyperphosphatemia in …
  • Firstmark Corporation:企業の戦略・SWOT・財務情報
    Firstmark Corporation - Strategy, SWOT and Corporate Finance Report Summary Firstmark Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Winbond Electronics Corporation (2344):企業の財務・戦略的SWOT分析
    Winbond Electronics Corporation (2344) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Sports Direct International Plc:企業の戦略・SWOT・財務情報
    Sports Direct International Plc - Strategy, SWOT and Corporate Finance Report Summary Sports Direct International Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Cielo Wind Power LP:企業の戦略的SWOT分析
    Cielo Wind Power LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Dunelm Group plc (DNLM):企業の財務・戦略的SWOT分析
    Dunelm Group plc (DNLM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Banco Comercial Portugues S.A:企業のM&A・事業提携・投資動向
    Banco Comercial Portugues S.A - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Banco Comercial Portugues S.A Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Sygnity SA (SGN):企業の財務・戦略的SWOT分析
    Sygnity SA (SGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Posco Chemtech Co Ltd:企業の戦略・SWOT・財務情報
    Posco Chemtech Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Posco Chemtech Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Coastal Contacts Inc-医療機器分野:企業M&A・提携分析
    Summary Coastal Contacts Inc (Coastal Contacts), a subsidiary of Essilor International is an online retailer that markets eye care products. The company's products include eyeglasses, contact lenses, sunglasses, vision care accessories, and others. Its contact lenses comprise daily wear colour lense …
  • SurModics Inc (SRDX):企業の財務・戦略的SWOT分析
    SurModics Inc (SRDX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Waters Corporation (WAT):医療機器:M&Aディール及び事業提携情報
    Summary Waters Corporation (Waters) is an analytical instrument manufacturing company. It carries out the design, production, commercialization and servicing of analytical technologies such as high performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC), chromatograp …
  • Merus Labs International Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Merus Labs International Inc (Merus Labs International), formerly Merus Labs Inc, a subsidiary of Norgine BV, is a pharmaceutical company that provides medicinal products. The company offers products in the therapeutic areas of cardiovascular, oncology support, women's health, urology, and i …
  • Koninklijke Philips N.V. (PHIA)-医療機器分野:企業M&A・提携分析
    Summary Koninklijke Philips N.V. (Philips) is a diversified technology company which focuses on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The company develops and manufactures medical …
  • Davide Campari-Milano S.p.A.:戦略・SWOT・企業財務分析
    Davide Campari-Milano S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Davide Campari-Milano S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • AF AB (AF B)-エネルギー分野:企業M&A・提携分析
    Summary AF AB is an engineering and consulting company. It offers various services such as product development and IT support to sectors including automotive, telecom, defense and life sciences. The company also provides services such as communications systems management, development of customized b …
  • Tien Phong Plastic (NTP):企業の財務・戦略的SWOT分析
    Tien Phong Plastic (NTP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Valaris Plc (VAL):企業の財務・戦略的SWOT分析
    Valaris Plc (VAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Tailored Brands, Inc.:企業の戦略・SWOT・財務情報
    Tailored Brands, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tailored Brands, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Southwest Airlines Co:戦略・SWOT・企業財務分析
    Southwest Airlines Co - Strategy, SWOT and Corporate Finance Report Summary Southwest Airlines Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆